Apriori Bio Announces Collaboration with the Francis Crick Institute
APRIApriori to leverage foundational insights from the Crick's Legacy Study to further validate Octavia™ platform's ability to predict viral evolution and vaccine performance CAMBRIDGE, Mass., Aug. 12, 2025 /PRNewswire/ -- Apriori Bio, a biotechnology company focused on developing...
August 12, 2025Collaboration
Read more →